Robert L. de Jager
Nessuna posizione attualmente
Profilo
Robert L.
de Jager worked as a Senior Director of Oncology Research & Development at Biogen, Inc. in 2006, Chief Medical Officer at Poniard Pharmaceuticals, Inc. in 2010, Chief Medical Officer & SVP-Clinical Development at Kosan Biosciences, Inc. in 2006-2007, and Chief Medical Officer at Conforma Therapeutics Corp.
in 2004-2006.
He also worked as a Principal at RGene Therapeutics, Inc. and as a Vice President of Research & Development at DaIIchi Pharma Holdings, Inc. Dr. de Jager received his undergraduate and doctorate degrees from Université Libre de Bruxelles.
Precedenti posizioni note di Robert L. de Jager
| Società | Posizione | Fine |
|---|---|---|
| PONIARD PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 05/02/2010 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Direttore Tecnico/Scientifico/R&S | 01/11/2007 |
| BIOGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2006 |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/05/2006 |
RGene Therapeutics, Inc.
 RGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Innoviva, Inc., RGene Therapeutics, Inc. is a company that specializes in the research and design of gene therapy. The company is based in The Woodlands, TX. The company was founded by Leaf Huang. RGene Therapeutics was acquired by AmpliPhi Biosciences Corp. on June 20, 1996 for $25 million. | Corporate Officer/Principal | - |
Formazione di Robert L. de Jager
| Université Libre de Bruxelles | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Health Technology |
RGene Therapeutics, Inc.
RGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Innoviva, Inc., RGene Therapeutics, Inc. is a company that specializes in the research and design of gene therapy. The company is based in The Woodlands, TX. The company was founded by Leaf Huang. RGene Therapeutics was acquired by AmpliPhi Biosciences Corp. on June 20, 1996 for $25 million. | Commercial Services |
| DaIIchi Pharma Holdings, Inc. |
- Borsa valori
- Insiders
- Robert L. de Jager
